サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：中国の肝炎治療薬の市場
市場調査レポート
商品コード
299933

中国の肝炎治療薬の市場

Hepatitis Drugs Markets in China
出版日: | 発行: Asia Market Information & Development Co. | ページ情報: 英文 196 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
中国の肝炎治療薬の市場
出版日: 2023年04月23日
発行: Asia Market Information & Development Co.
ページ情報: 英文 196 Pages
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、中国の肝炎治療薬市場の現状と将来予測（過去5～10年間の実績値および今後5～10年間の予測値）を分析し、全体的なビジネス環境や、市場動向（売上高・消費量・貿易量）とその見通し、市場参入戦略、関係企業一覧などの情報を盛り込み、概略下記の構成でお届けいたします。

第1章　イントロダクション

  • 分析範囲・手法
  • エグゼクティブ・サマリー

第2章　ビジネス環境

  • 経済展望
    • 主要経済指標
    • 工業生産
    • 人口・労働力
    • 直接投資
    • 対外貿易
  • 金融・税務規制
    • 銀行システムと規制
    • 外国為替
    • 税制と関税

第3章　肝炎治療薬産業の評価

  • 肝炎治療薬産業の構造
  • 市場規模
  • 市場成長の促進要因
  • 肝炎治療薬産業の売上高
  • 主要メーカーの生産拠点・売上高
  • 主要メーカーの市場シェア
  • 人件費
  • 潜在的な参入企業
  • 主な流通業者
  • 主な外資系企業
  • 技術開発

第4章　肝炎治療薬の生産量・需要量

  • 概要
  • 各地域の肝炎治療薬の売上高
  • 肝炎治療薬の売上高
    • 肝臓保護薬
    • ヌクレオシド薬
    • インターフェロン(IFN)
    • その他
  • 肝炎治療薬の輸出額・輸入額
    • 輸入額
    • 輸出額
  • 価格動向

第5章　肝炎治療薬の消費量の見通し

  • 肝炎治療薬市場の将来展望：概要
  • 政府の規制
  • 医療保険産業の概要
  • 医療費支出額の動向
  • 人口動向
  • 医療産業の動向
  • 病院数および病床数
  • 医師数および往診回数

第6章　マーケティング戦略

  • 中国市場の概要
    • 中国の流通システム
    • 流通経路
    • 交通・貨物輸送インフラ
    • 通信
  • 中国市場への参入経路
    • ライセンス契約
    • フランチャイズ
    • 電子商取引（eコマース）
    • 商社と現地代理店
    • 現地事務所と中国国内の子会社
    • 独資企業

第7章　肝炎治療薬メーカーの一覧

  • 肝炎治療薬メーカーのプロファイル

図表一覧

図表

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

  • Hepatitis Drugs Industry Sales Volumes
  • Major Producer Facility Locations
  • Major Hepatitis Drugs Producer Sales Volumes
  • Market Share of Key Producers
  • Major Foreign Investments in China

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

  • Hepatitis Drugs Sales Volumes
  • Sales Volumes of Hepatitis Drugs by Region
  • Major Liver Protection Drugs Producer Sales Volumes
  • Liver Protection Drugs Sales Volumes
  • Major Nucleoside Drugs Producer Sales Volumes
  • Nucleoside Drugs Sales Volumes
  • Major IFN Drugs Producer Sales Volumes
  • Interferon (IFN) Sales Volumes
  • Other Hepatitis Drugs Sales Volumes
  • China Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK

  • Total hepatitis Drugs Sales Volumes by Market
  • Hepatitis Drugs Sales Volumes and Market Share
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China's Hepatitis Drugs Sales Volumes

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

  • Hepatitis Drugs Sales Volumes in China

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

  • Total Hepatitis Drugs Sales Volumes
  • Total Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK

  • Hepatitis Drugs Sales Volumes by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel
目次
Product Code: 807

China's demand for Hepatitis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

  • Hepatitis Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Hepatitis Drugs Industry Sales Volumes
  • Major Producer Facility Locations and Sales Volumes
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

  • Overview
  • Sales Volumes of Hepatitis Drugs by Region
  • Hepatitis Drugs Sales Volumes
  • Liver Protection Drugs
  • Nucleoside Drugs
  • Interferon (IFN)
  • Other Hepatitis Drugs
  • Hepatitis Drugs Imports and Exports
  • Hepatitis Drugs Imports
  • Hepatitis Drugs Exports
  • Pricing Trend

V. HEPATITIS DRUGS MARKET OUTLOOK

  • Hepatitis Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Hepatitis Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. HEPATITIS DRUGS PRODUCER DIRECTORY

  • Hepatitis Drugs Producer Profiles